In this study, we demonstrated that miR-135a-5p inhibits in vivo and in vitro growth of CRC by targeting ERp29; correspondingly, ERp29 acts as an oncoprotein in CRC by promoting proliferation and metastasis of CRC cells, and suppressing apoptosis of the cells. The gene discussed is ERP29; the disease is colorectal carcinoma.